The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects
It seems like no matter where you go, from a family braai to office chatter, or even just…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…